156 related articles for article (PubMed ID: 22407924)
1. Novel brain targeting prodrugs of naproxen based on dimethylamino group with various linkages.
Zhang Q; Liang Z; Chen LY; Sun X; Gong T; Zhang ZR
Arzneimittelforschung; 2012 Jun; 62(6):261-6. PubMed ID: 22407924
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, in vitro and in vivo characterization of glycosyl derivatives of ibuprofen as novel prodrugs for brain drug delivery.
Chen Q; Gong T; Liu J; Wang X; Fu H; Zhang Z
J Drug Target; 2009 May; 17(4):318-28. PubMed ID: 19558357
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and biological evaluation of brain-specific glucosyl thiamine disulfide prodrugs of naproxen.
Fan W; Wu Y; Li XK; Yao N; Li X; Yu YG; Hai L
Eur J Med Chem; 2011 Sep; 46(9):3651-61. PubMed ID: 21641697
[TBL] [Abstract][Full Text] [Related]
4. Diacyl glyceryl ester prodrugs for slow release in the skin: synthesis and in vitro degradation and absorption studies for naproxen derivatives.
Thorsteinsson T; Másson M; Loftsson T; Haraldsson GG; Stefánsson E
Pharmazie; 1999 Nov; 54(11):831-6. PubMed ID: 10603609
[TBL] [Abstract][Full Text] [Related]
5. In vitro evaluation of dendrimer prodrugs for oral drug delivery.
Najlah M; Freeman S; Attwood D; D'Emanuele A
Int J Pharm; 2007 May; 336(1):183-90. PubMed ID: 17188439
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and ulcerogenic studies of naproxen prodrugs designed for specific brain delivery.
Sheha M
Arch Pharm Res; 2012 Mar; 35(3):523-30. PubMed ID: 22477200
[TBL] [Abstract][Full Text] [Related]
7. Brain-specific delivery of naproxen using different carrier systems.
Mahmoud S; Mohammad A
Arch Pharm (Weinheim); 2010 Nov; 343(11-12):639-47. PubMed ID: 21110306
[TBL] [Abstract][Full Text] [Related]
8. Improved brain delivery of a nonsteroidal anti-inflammatory drug with a synthetic glyceride ester: a preliminary attempt at a CNS drug delivery system for the therapy of Alzheimer's disease.
Deguchi Y; Hayashi H; Fujii S; Naito T; Yokoyama Y; Yamada S; Kimura R
J Drug Target; 2000; 8(6):371-81. PubMed ID: 11328663
[TBL] [Abstract][Full Text] [Related]
9. Prolonged naproxen joint residence time after intra-articular injection of lipophilic solutions comprising a naproxen glycolamide ester prodrug in the rat.
Thing M; Lu Y; Agårdh L; Larsen C; Ostergaard J; He W; Wu W; Larsen F; Larsen SW
Int J Pharm; 2013 Jul; 451(1-2):34-40. PubMed ID: 23624087
[TBL] [Abstract][Full Text] [Related]
10. Oral colon targeted delivery systems for treatment of inflammatory bowel diseases: synthesis, in vitro and in vivo assessment.
El-Kamel AH; Abdel-Aziz AA; Fatani AJ; El-Subbagh HI
Int J Pharm; 2008 Jun; 358(1-2):248-55. PubMed ID: 18502065
[TBL] [Abstract][Full Text] [Related]
11. Potential prodrugs of non-steroidal anti-inflammatory agents for targeted drug delivery to the CNS.
Perioli L; Ambrogi V; Bernardini C; Grandolini G; Ricci M; Giovagnoli S; Rossi C
Eur J Med Chem; 2004 Aug; 39(8):715-27. PubMed ID: 15276305
[TBL] [Abstract][Full Text] [Related]
12. Modification of concomitant drug release from oil vehicles using drug-prodrug combinations to achieve sustained balanced analgesia after joint installation.
Thing M; Jensen SS; Larsen C; Østergaard J; Larsen SW
Int J Pharm; 2012 Dec; 439(1-2):246-53. PubMed ID: 23010284
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization and stability of dendrimer prodrugs.
Najlah M; Freeman S; Attwood D; D'Emanuele A
Int J Pharm; 2006 Feb; 308(1-2):175-82. PubMed ID: 16384673
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and neuroprotective effects of dual-brain targeting naproxen prodrug.
Wang L; Zhang L; Zhao Y; Fu Q; Xiao W; Lu R; Hai L; Guo L; Wu Y
Arch Pharm (Weinheim); 2018 May; 351(5):e1700382. PubMed ID: 29566434
[TBL] [Abstract][Full Text] [Related]
15. Dose dependent pharmacokinetics of naproxen in man.
Niazi SK; Alam SM; Ahmad SI
Biopharm Drug Dispos; 1996 May; 17(4):355-61. PubMed ID: 8743406
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro evaluation of novel morpholinyl- and methylpiperazinylacyloxyalkyl prodrugs of 2-(6-methoxy-2-naphthyl)propionic acid (Naproxen) for topical drug delivery.
Rautio J; Nevalainen T; Taipale H; Vepsäläinen J; Gynther J; Laine K; Järvinen T
J Med Chem; 2000 Apr; 43(8):1489-94. PubMed ID: 10780905
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic studies of naproxen amides of some amino acid esters with promising colorectal cancer chemopreventive activity.
Aboul-Fadl T; Al-Hamad SS; Fouad EA
Bioorg Chem; 2018 Feb; 76():370-379. PubMed ID: 29241109
[TBL] [Abstract][Full Text] [Related]
18. Brain uptake of ketoprofen-lysine prodrug in rats.
Gynther M; Jalkanen A; Lehtonen M; Forsberg M; Laine K; Ropponen J; Leppänen J; Knuuti J; Rautio J
Int J Pharm; 2010 Oct; 399(1-2):121-8. PubMed ID: 20727958
[TBL] [Abstract][Full Text] [Related]
19. Gastric-sparing nitric oxide-releasable 'true' prodrugs of aspirin and naproxen.
Gund M; Gaikwad P; Borhade N; Burhan A; Desai DC; Sharma A; Dhiman M; Patil M; Sheikh J; Thakre G; Tipparam SG; Sharma S; Nemmani KVS; Satyam A
Bioorg Med Chem Lett; 2014 Dec; 24(24):5587-5592. PubMed ID: 25466180
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterisation of polyphosphazene-based controlled release systems for naproxen.
Caliceti P; Lora S; Marsilio F; Veronese FM
Farmaco; 1995 Dec; 50(12):867-74. PubMed ID: 8634078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
